NCT07137689View on ClinicalTrials.gov

A Study of LY3537982 in Participants With Kidney Problems Compared With Participants With Normal Kidney Function

PHASE1RecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 18, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Renal Insufficiency
Interventions
DRUG

LY3537982

Administered orally

Trial Locations (4)

32216

RECRUITING

Jacksonville Center for Clinical Research, Jacksonville

32809

RECRUITING

Orlando Clinical Research Center, Orlando

33014

RECRUITING

Panax Clinical Research, Miami Lakes

33603

RECRUITING

Genesis Clinical Research, Tampa

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY